Home » Topics » BioWorld Science

BioWorld Science
RSS

CARB-X award supports BioVersys' development of antimicrobial therapies

Oct. 29, 2019

AstraZeneca reports promising PFS data with Imfinzi and tremelimumab in stage IV NSCLC

Oct. 29, 2019

European Commission approves Bavencio with axitinib for first-line advanced RCC

Oct. 29, 2019

Ziopharm and MD Anderson agree to expand TCR-T program

Oct. 29, 2019

New adenosine A2A receptor antagonists disclosed by BeiGene

Oct. 29, 2019

Flex Pharma synthesizes voltage-gated sodium channel blockers

Oct. 29, 2019

GlaxoSmithKline identifies new ATF-4 inhibitors

Oct. 29, 2019

BioCryst Pharmaceuticals discloses complement factor D inhibitors

Oct. 29, 2019

TG reports promising data from phase II UNITY-NHL trial of umbralisib in follicular lymphoma

Oct. 29, 2019

Iveric Bio's phase IIb study of Zimura for geographic atrophy in dry AMD meets primary endpoint

Oct. 29, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...